Trauma-Induced coagulopathy: From biology to therapy

Seminars in Hematology

Volumn 50, Issue 3, 2013, Pages 259-269

  Noel, Pierre ^a   Cashen, Steven ^a   Patel, Bhavesh ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; BETA CATENIN; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; HETASTARCH; PLACEBO; PROTEIN C; PROTEIN S; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SODIUM CHLORIDE; SYNDECAN 1; THROMBOMODULIN; TRANEXAMIC ACID;

ACIDOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR DEFICIENCY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM INJURY; ERYTHROCYTE TRANSFUSION; GLYCOCALYX; HEMATOLOGIC DISEASE; HEMODILUTION; HEMOSTASIS; HUMAN; HYPERFIBRINOLYSIS; HYPOTHERMIA; INDUCED HYPOTENSION; INJURY; LABORATORY DIAGNOSIS; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTHROMBIN TIME; RESUSCITATION; RISK BENEFIT ANALYSIS; THROMBOCYTE DYSFUNCTION; THROMBOELASTOGRAPHY; THROMBOEMBOLISM;

ACUTE DISEASE; ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; HUMANS; WOUNDS AND INJURIES;

EID: 84881604250     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2013.06.009     Document Type: Article

References (117)

1. Peden M., McGee K., Sharma G. The injury chart book: a graphical overview of the global burden of injuries 2002, World Health Organization, Geneva.
2. Sauaia A., Moore F.A., Moore E.E., et al. Epidemiology of trauma deaths: a reassessement. J Trauma 1995, 38:185-193.
3. Hess J.R. Blood and coagulation support in trauma care. Hematology Am Soc Hematol Educ Program 2007, 187-191.
4. Brohi K., Singh J., Heron M., Coats T. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130.
5. MacLeod J.B., Lynn M., Mckenney M.G., Cohn S.M., Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003, 55:39-44.
6. Brohi K., Cohen M.J., Ganter M.T., Mathay M.A., Mackersie R.C., Pittet J.F. Acute traumatic coagulopathy:initiated by hypoperfusion:modulated through the protein C pathway?. Ann Surg 2007, 245:812-818.
7. Ganter M.T., Brohi K., Cohen M.J., et al. Role of the alternative pathway in the early complement activation. Shock 2007, 28:29-34.
8. Johansson P.L., Stensballe J., Rasmussen L.S., Ostrowski S.R. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011, 254:194-200.
9. Johansson P.L., Stensballe J., Rasmussen L.S., Ostrowski S.R. High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma 2012, 72:428-436.
10. Anastasiou G., Gialeraki A., Merkouri E., Politou M., Travlou A. Thrombomodulin as a regulator of the anticoagulant pathway:implication in the development of thrombosis. Blood Coagul Fibrinolysis 2012, 23:1-10.
11. Lowenstein C.J., Morrell C.N., Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med 2005, 15:302-308.
12. Senzolo M., Coppell, Cholongitas E., et al. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis 2007, 18:227-236.
13. Ostrowski S.R., Johansson P.I. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg 2012, 73:60-66.
14. Becker B.F., Chappell D., Bruegger D., Annecke T., Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010, 87:300-310.
15. Reitsma S., Slaaf D.W., Vink H., van Zandvoort M.A., oude Egbrink MG The endothelial glycocalyx:composition, functions, and visualization. Pflugers Arch 2007, 454:345-359.
16. Fiedler U., Augustin H.G. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006, 27:552-558.
17. Aird W.C. Endothelium as an organ system. Crit Care Med 2004, 32:S271-S279.
18. Pries A.R., Secomb T.W., Gaehtgens P. The endothelium surface layer. Pfugers Arch 2000, 440:653-666.
19. Nieuedorp M., Meuwese M.C., Vink H., et al. The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 2005, 16:507-511.
20. Ten V.S., Pinsky D.j. Endothelial response to hypoxia:physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 2002, 8:242-250.
21. Rehm M., Bruegger D., Christ F., Conzen P., et al. Shedding of the glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007, 116:1896-1906.
22. Ganter M.T., Cohe M.J., Borji K., et al. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?. Ann Surg 2008, 247:320-326.
23. Ostrowski S.R., Sorensen A.M., Windelov N.A., et al. High levels of soluble VEGF receptor 1 early after trauma are associated with schock, sympothoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study. Scand J Trauma Resusc Emerg Med 2012, 20:27:1-8.
24. Haywood-Watson R., Pati S., Kozar R., et al. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One 2011, 6:e23530.
25. Pati S., Matijevic N., Doursout M.F., et al. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma 2010, 69(Suppl 1):S55-S63.
26. Kozar R.A., Peng Z., Zhang R., et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 2011, 112:1289-1295.
27. Kumar P., Shen Q., Pivetti C.D., et al. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med 2009, 11:e19.
28. Childs E.W., Tharakan B., Byrge N., et al. Angiopoietin-1 inhibits intrinsic apoptotic signaling and vascular hyperpermeability following hemorrhagic shock. Am J Physiol Heart Circ Physiol 2008, 294:H2285-H2295.
29. Dejana E., Bazzoni G., Lampugnani M.G. Vascular endothelial (VE)-cadherin: only an intercellular glue?. Exp Cell Res 1999, 252:13-19.
30. Hinck L., Nathke I.S., Papkoff J., Nelson W.J. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994, 125:1327-1340.
31. Savant D.A., Tharakan B., Hunter F.A., Smythe W.R., Childs E.W. Role of β-catenin in regulating microvascular endothelial cell hyperpermeability. J Trauma 2011, 70:481-488.
32. Johansson P.I., Ostrowski S.R. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses 2010, 75:564-567.
33. Espana F., Medina P., Navarro S., et al. The multifounctional protein C system. Curr Med Chem Cardiovasc Hematol Agents 2005, 3:119-131.
34. Rezaie A.R. Regulation of the protein C anticoagulant and anti-inflammatory pathways. Curr Med Chem 2010, 17:2059-2069.
35. Anastasiou G., Gialeraki A., Merkouri W., Politou M., Travlou A. Thrombomodulin as a regulator of the anticoagulant pathway:implication in the development of thrombosis. Blood Coagul Fibrinolysis 2011, 23:1-10.
36. Disse J., Petersen H.H., Larsen K.S., et al. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. J Biol Chem 2011, 286:5756-5767.
37. Stearns-Kurosawa D.J., Kurosawa S., Mollica J.S., et al. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A 1996, 93:10212-10216.
38. Navarro S., Bonet E., Estelles A., et al. The endothelial cell protein S receptor: Its role in thrombosis. Thromb Res 2011, 128:410-416.
39. Esmon C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989, 264:4743-4746.
40. Laszik Z., Mitro A., Taylor F.B., et al. Human protein C receptor is present primarily on endothelium of large vessels: implications for the control of the protein C pathway. Circulation 1997, 96:3633-3640.
41. Esmon C.T. The protein C pathway. Chest 2003, 124:26S-32S.
42. Dahlback B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway. Novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol. 2005;25:1311-20.
43. Floccard B., Rugeri L., Faure A., et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012, 43:26-32.
44. Rizoli S.B., Scarpelini S., Callum J., et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma 2011, 71(5 Suppl 1):S427-S434.
45. Jansen J.O., Scarpelini S., Pinto R., et al. Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity. J Trauma 2011, 71(5 Suppl 1):S435-40.
46. Rourke C., Curry N., Khan S., et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012, 10:1342-1351.
47. Kutcher M.E., Cripps M.W., McCreery R.C., et al. Criteria for empiric treatment of hyperfibrinolysis after trauma. J Trauma 2012, 73:87-93.
48. Holcomb J.B., Minei K.M., Scerbo M.L., et al. Admission rapid thromboelastography can replace conventional coagulation tests in the ermergency department. Ann Surg 2012, 256:476-486.
49. Tauber H., Innerhofer P., Breitkopf R., et al. Prevalence and impact of abnormal Rotem assays in severe blunt trauma: results of the "Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study. Br J Anaesth 2011, 107:378-387.
50. Theusinger O.M., Wanner G.A., Emmert M.Y., et al. Hyperfibrinolysis diagnosed by Rotational Thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011, 113:1003-1012.
51. Ives C., Inaba K., Branco B.C., et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg 2012, 215:496-502.
52. Rizoli S., Nascimento B., Key N., et al. Disseminated intravascular coagulopathy in the first 24 hours after trauma: the association between ISTH score and anatomopathologic evidence. J Trauma 2011, 71:S441-S447.
53. Wohlauer M.V., Moore E.E., Thomas S., et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg 2012, 214:739-746.
54. Kutcher M.E., Redick B.J., McCreery R.C., et al. Characterization of platelet dysfunction after trauma. J Trauma 2012, 73:13-19.
55. Lier H., Krep H., Schroeder S., Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008, 65:951-960.
56. Dirkmann D., Hanke A.A., Gorlinger K., Peters J. Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 2008, 106:1627-1632.
57. Hess J.R., Brohi K., Dutton R.P., et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008, 65:748-754.
58. Simmons J.W., White C.E., Ritchie J.S., et al. Mechanism of injury affects acute coagulopathy of trauma in combat casualties. J Trauma 2011, 71:S74-S77.
59. Luna G.K., Maier R.V., Pavlin E.G., et al. Incidence and effect of hypothermia in seriously injured patients. J Trauma 1987, 27:1014-1018.
60. Watts D.D., Trask A., Soeken K., et al. Hypothermic coagulopathy in trauma:effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998, 44:846-854.
61. Wolberg A.S., Meng Z.H., Monroe D.M., Hoffman M. A systemic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004, 56:1221-1228.
62. Martini W.Z. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma 2009, 67:202-209.
63. Waibel B.H., Schlitzkus L.L., Newell M.A., et al. Impact of hypothermia (below 36 degree C) in the rural trauma patient. J Am Coll Surg 2009, 209:580-588.
64. Meng Z.H., Wolberg A.S., Monroe D.M., Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003, 55:886-889.
65. Martini W.Z., Holcomb J.B. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg 2007, 246:831-835.
66. Hess J.R., Lawson J.H. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006, 60(Suppl 6):S12-S19.
67. Brazil E.V., Coats T.J. Sonoclot coagulation analysis of in-vitro haemodilution with resuscitation solutions. J R Soc Med 2000, 93:507-510.
68. Coats T.J., Brazil E., Heron M., MacCallum P.K. Impairment of coagulation by commonly used resuscitation fluids in human volunteers. Br Med J 2006, 23:846-849.
69. Maegele M., Lefering R., Yucel N., et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007, 38:298-304.
70. Fries D., Martini W.Z. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010, 105:116-121.
71. Howard B.M., Daley A.T., Cohen M.J. Prohemostatic interventions in trauma: resuscitation-associated coagulopathy, acute traumatic coagulopathy, hemostatic resuscitation, and other hemostatic interventions. Semin Thromb Hemost 2012, 38:250-258.
72. Davenport R., Khan S. Management of major trauma hemorrhage:treatment priorities and controversies. Br J Haematol 2011, 155:537-548.
73. Tripodi A., Chantarangkul V., Manucci P.M. Acquired coagulation disorders:revisited using global coagulation/anticoagulation testing. Br J Haematol 2009, 147:77-82.
74. Yuan S., Ferrell C., Chandler W.L. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res 2007, 120:29-37.
75. Frith D., Goslings J.C., Gaarder C., et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010, 8:1919-1925.
76. Victor J., Zimmermann H., Can Exadaktylos A.K. Rapid TEG accelerate the search for coagulopathies in the patient with multiple injuries?. J Trauma 2009, 66:1253-1257.
77. Curry N., Davis P.W. What's new in resuscitation strategies for the patient with multiple trauma?. Injury 2012, 43:1021-1028.
78. Holcomb J.B., Minei K.M., Scerbo M.L., et al. Admission rapid thromboelastography can replace conventional coagulation tests in the emergency department. Ann Surg 2012, 256:476-486.
79. Cotton B.A., Reddy N., Hatch Q.M., et al. Damage control resuscitation is associated with a reduction in resuscitative volumes and improved survival in 390 damage control laparotomy patients. Ann Surg 2011, 254:598-605.
80. Curry N., Davis P.W. What's new in resuscitation strategies for the patient with multiple trauma?. Injury Int J Care Injured 2012, 43:1021-1028.
81. Gruen R.L., Brohi K., Schreiber M., et al. Haemorrhage control in severely injured patients. Lancet 2012, 380:1099-1108.
82. Jaunoo S.S., Harji D.P. Damage control surgery. Int J Surg 2009, 7:110-113.
83. Bickell W.H., Wall M.J., Pepe P.E., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso trauma. N Engl J Med 1994, 331:1105-1109.
84. Morrison C.A., Carrick M.M., Norman M.A., et al. Hypotensive resuscitation strategy reduces transfusion requiremnts and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial. J Trauma 2011, 70:652-663.
85. Duke M.D., Guidry C., Guice J., et al. Restrictive fluid resuscitation in combination with damage control resuscitation: time for adaptation. J Trauma 2012, 73:674-678.
86. Bulger E.M., May S., Kerby J.D., et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg 2011, 253:431-441.
87. James M.F., Mitchell W.L., Joubert I.A., et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011, 107:693-702.
88. Myburgh J.A., Finfer S., Bellomo R., et al. Hydoxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012, 367:1901-1911.
89. Perner A., Haase N., Guttormsen A.B., et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134.
90. Stanworth SJ, Morris TP, Gaarder C, et al. Reappraising the concept of massive transfusion in trauma. Crit Care. 2010;R239.
91. Borgman M.A., Spinella P.C., Perkins J.G., et al. The ratio of blood products transfused affects the mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
92. Spinella P.C., Perkins J.G., Gratwohl K.W., et al. Effect of plasma and red cell transfusions on survival in patients with combat related traumatic injuries. J Trauma 2008, 64:S69-78.
93. Callum J.L., Rizoli S. Plasma transfusion for patients with severe hemorrhage: what is the evidence. Transfusion 2012, 52:30S-37S.
94. Scalea T.M., Bochicchio K.M., Lumpkins K., et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injures trauma patients. Ann Surg 2008, 248:578-584.
95. Dirks J., Jorgensen H., Jensen C.H., et al. Blood product ratio in acute traumatic coagulopathy-effect on mortality in a Scandinavian level 1 trauma center. Scand J Trauma Resusc 2010, 18:65.
96. Ho A.M., Dion P.W., Yeung J.H., et al. Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology 2012, 116:716-728.
97. Holcomb J.B., del Junco D.J., Fox E.E., et al. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study. Arch Surg 2012, Oct, 15:1-10. [Epub ahead of print]. 10.1001/2013.jamasurg.387.
98. Holcomb J.B., Zarzabal L.A., Michalek J.E., et al. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011, 71:S318-S328.
99. Spinella P.C., Wade C.E., Blackbourne L.H., et al. The association of blood component use ratios with the survival of massively transfused trauma patients with and without brain injury. J Trauma 2011, 71:S343-S352.
100. Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR). Clinical Trails.gov Identifier: NCT01545232. (). http://www.clinicaltrials.gov/ct2/show/NCT01545232?term=PROPPR&rank=1.
101. Spinella P.C., Perkins J.G., Grathwohl K.W., et al. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009, 66:S69-S76.
102. Lelubre C., Piagnerelli M., Vincent J.-L. Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality?. Transfusion 2009, 49:1384-1394.
103. Zehtabchi S., Nishijima D.K. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 2009, 16:371-378.
104. Sorensen B., Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012, 99:40-50.
105. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised trial. Lancet 2011, 377:1096-1101. The CRASH-2 collaborators.
106. Roberts I., Perel P., Prieto-Merino D., et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomized controlled trial. BMJ 2012, 345:e5839.
107. Morrison J.J., Dubose J.J., Rasmussen T.E., Midwinter MJ Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg 2012, 147:113-119.
108. Dirkmann D., Gorlinger K., Gisbertz C., Dusse F., Peters J. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood. Anesth Analg 2012, 114:1182-1188.
109. Spinella P.V., Perkins J.G., McLaughlin D.F., et al. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma 2008, 64:286-293.
110. Boffard K.D., Riou B., Warren B., et al. Recombiant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005, 59:8-15.
111. Hauser C.J., Boffard K., Dutton R., et al. Result of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010, 69:489-500.
112. Lin Y., Stanworth S., Birchall J., Doree C., Hyde C. Use of recombinant factor VIIa or the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis. CMAJ 2011, 183:E9-E19.
113. Zaaroor M., Soustiel J.F., Brenner B., et al. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy. Acta Neurochir 2008, 150:663-668.
114. Sorensen B., Spahn D.R., Innerhofer P., et al. Clinical review: prothombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care 2011, 15:201.
115. Bellal J., Amini A., Friese R.S., et al. Factor IX complex for the correction of traumatic coagulopathy. J Trauma 2012, 72:828-834.
116. Stinger H.K., Spinella P.C., Perkins J.G., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008, 64:S79-S85.
117. Schochl H., Nienaber U., Maegele M., et al. Transfusion in trauma: thromboelastography-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011, 15:R83.